AFN50 injection
PJ-2025-12-57
Phase 1 mab active
Quick answer
AFN50 injection for Autoimmune Diseases is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Autoimmune Diseases
- Phase
- Phase 1
- Modality
- mab
- Status
- active